Terms: = Brain cancer AND STAT5B, STAT5, 6777, ENSG00000173757, P51692 AND Treatment
12 results:
1. Myb Repression Mediates stat5b-knockdown-induced Apoptosis and Inhibits Proliferation of Glioblastoma Stem Cells.
Moyama C; Fujita M; Okamoto H; Ii H; Nakata S
Cancer Genomics Proteomics; 2023; 20(2):195-202. PubMed ID: 36870690
[TBL] [Abstract] [Full Text] [Related]
2. stat5b is a marker of poor prognosis, rather than a therapeutic target in glioblastomas.
Dubois N; Berendsen S; Tan K; Schoysmans L; Spliet W; Seute T; Bours V; Robe PA
Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 36069226
[TBL] [Abstract] [Full Text] [Related]
3. Tumor-related molecular determinants of neurocognitive deficits in patients with diffuse glioma.
van Kessel E; Berendsen S; Baumfalk AE; Venugopal H; Krijnen EA; Spliet WGM; van Hecke W; Giuliani F; Seute T; van Zandvoort MJE; Snijders TJ; Robe PA
Neuro Oncol; 2022 Oct; 24(10):1660-1670. PubMed ID: 35148403
[TBL] [Abstract] [Full Text] [Related]
4. Pimozide augments bromocriptine lethality in prolactinoma cells and in a xenograft model via the stat5/cyclin D1 and stat5/Bcl‑xL signaling pathways.
Xiao Z; Liang J; Deng Q; Song C; Yang X; Liu Z; Shao Z; Zhang K; Wang X; Li Z
Int J Mol Med; 2021 Jan; 47(1):113-124. PubMed ID: 33155660
[TBL] [Abstract] [Full Text] [Related]
5. MiR-920 and LSP1 co-regulate the growth and migration of glioblastoma cells by modulation of JAK2/stat5 pathway.
Cong P; Hou HY; Wei W; Zhou Y; Yu XM
J Bioenerg Biomembr; 2020 Oct; 52(5):311-320. PubMed ID: 32770294
[TBL] [Abstract] [Full Text] [Related]
6. Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma.
Elmaci I; Altinoz MA
Crit Rev Oncol Hematol; 2018 Aug; 128():96-109. PubMed ID: 29958636
[TBL] [Abstract] [Full Text] [Related]
7. EGFRvIII-stat5 Signaling Enhances Glioblastoma Cell Migration and Survival.
Roos A; Dhruv HD; Peng S; Inge LJ; Tuncali S; Pineda M; Millard N; Mayo Z; Eschbacher JM; Loftus JC; Winkles JA; Tran NL
Mol Cancer Res; 2018 Jul; 16(7):1185-1195. PubMed ID: 29724813
[TBL] [Abstract] [Full Text] [Related]
8. Combination of an anti-EGFRvIII antibody CH12 with Rapamycin synergistically inhibits the growth of EGFRvIII+PTEN-glioblastoma in vivo.
Xu W; Bi Y; Kong J; Zhang J; Wang B; Li K; Tian M; Pan X; Shi B; Gu J; Jiang H; Kong X; Li Z
Oncotarget; 2016 Apr; 7(17):24752-65. PubMed ID: 27029073
[TBL] [Abstract] [Full Text] [Related]
9. Activation of stat5 contributes to proliferation in U87 human glioblastoma multiforme cells.
Feng C; Cao S
Mol Med Rep; 2014 Jul; 10(1):203-10. PubMed ID: 24821382
[TBL] [Abstract] [Full Text] [Related]
10. Preclinical characterization of signal transducer and activator of transcription 3 small molecule inhibitors for primary and metastatic brain cancer therapy.
Assi HH; Paran C; VanderVeen N; Savakus J; Doherty R; Petruzzella E; Hoeschele JD; Appelman H; Raptis L; Mikkelsen T; Lowenstein PR; Castro MG
J Pharmacol Exp Ther; 2014 Jun; 349(3):458-69. PubMed ID: 24696041
[TBL] [Abstract] [Full Text] [Related]
11. [New insights in growth hormone physiology and pathophysiology].
Kamenicky P; Lombès M; Chanson P
Ann Endocrinol (Paris); 2010 Sep; 71 Suppl 1():S25-32. PubMed ID: 21237327
[TBL] [Abstract] [Full Text] [Related]
12. Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling.
Scoles DR; Nguyen VD; Qin Y; Sun CX; Morrison H; Gutmann DH; Pulst SM
Hum Mol Genet; 2002 Dec; 11(25):3179-89. PubMed ID: 12444102
[TBL] [Abstract] [Full Text] [Related]
